Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-03

FDA Approved: ALLOPURINOL — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Allopurinol from Actavis Pharma, Inc., authorizing changes to the product’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

SUPPL AP for ALLOPURINOL (ALLOPURINOL)